Sign In
Buy VERU
$2.77
+0.440 (+18.88%)
At Close: Aug 10, 2026
Veru reports cancer drug has high potential to reduce Covid-19 deaths
08:13pm, Monday, 08'th Feb 2021
Dr. Mitchell Steiner, chief executive of drugmaker Veru, said a Phase 2 trial of VERU-111 showed an 82% relative reduction in Covid-19 patient mortality versus placebo.
Veru CEO says cancer drug has potential to prevent Covid-19 deaths
07:35pm, Monday, 08'th Feb 2021
Veru CEO Dr. Mitchell Steiner explained how VERU-111, a prostate cancer drug developed by the biotech company, could be used as an anti-inflammatory and antiviral treatment to help patients diagnosed
Why Veru Stock Is Skyrocketing Today
11:53am, Monday, 08'th Feb 2021
The company reported great results from a phase 2 study in treating hospitalized COVID-19 patients.
VERU Stock Price Increases Over 20% Pre-Market: Why It Happened
09:13am, Monday, 08'th Feb 2021
The stock price of Veru Inc (NASDAQ: VERU) is trading at over 20% pre-market. This is why it happened.
Veru's COVID-19 Drug Candidate Shows High Relative Reduction In Treatment Failures, Mortality In Mid-Stage Study
08:40am, Monday, 08'th Feb 2021
Veru Inc (NASDAQ: VERU) rises sharply after announcing positive efficacy and safety results from a Phase 2 trial evaluating VERU-111 versus placebo in approximately 40 hospitalized patients at h
– Potential for two-pronged action against COVID-19 as an antiviral and anti-inflammatory agent supported by Phase 2 clinical study results –
Will Female Health Company The (VERU) Report Negative Earnings Next Week? What You Should Know
01:38pm, Wednesday, 03'rd Feb 2021
Female Health Company The (VERU) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Veru to Report Fiscal 2021 First-Quarter Financial Results, Host Conference Call on February 10th
08:30am, Wednesday, 27'th Jan 2021
MIAMI, Jan. 27, 2021 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), an oncology biopharmaceutical company with a focus on developing novel medicines for the management of prostate and breast cancer, to
Is The Rally In Veru Overdone?
07:30am, Tuesday, 12'th Jan 2021
After a stellar 3x rise since the March 23 levels of last year, at the current price of around $10 per share we believe Veru Inc. stock, a biopharmaceuticals company focused on oncology medicines, has
Veru to Present at the H.C. Wainwright Bioconnect 2021 Conference on January 11th, 2021
08:30am, Monday, 04'th Jan 2021
MIAMI, Jan. 04, 2021 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), an oncology biopharmaceutical company with a focus on developing novel medicines for the management of prostate and breast cancer, to
Implied Volatility Surging for Veru (VERU) Stock Options
09:47am, Tuesday, 15'th Dec 2020
Investors need to pay close attention to Veru (VERU) stock based on the movements in the options market lately.
Veru's stock soars again on heavy volume after positive results of breast cancer treatment
02:53pm, Monday, 14'th Dec 2020
Shares of Veru Inc. soared 51.4% toward a seven-year high on massive volume, after the biopharmaceutical company announced positive results from a Phase 2 study of its treatment of breast cancer. Trad
5 Biopharma Stocks Making Big Moves Monday
11:33am, Monday, 14'th Dec 2020
Even as the broader market trades higher in reaction to the availability of the first coronavirus vaccine under emergency use authorization, a slew of biopharma stocks are moving on company-specific u
VERU Stock News: 9 Things for Investors to Know About Veru Breast Cancer Trial Results
10:49am, Monday, 14'th Dec 2020
Veru (VERU) stock is doing well on Monday after announcing positive news from a Phase 2 clinical trial of its breast cancer drug. The post VERU Stock News: 9 Things for Investors to Know About Veru Br
-- Phase 2 Multicenter, International Clinical Study Selected as Spotlight Presentation at 2020 San Antonio Breast Cancer Symposium –
